Literature DB >> 15618166

Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on toll-like receptor 2.

Abdul Q Khan1, Quanyi Chen, Zheng-Qi Wu, James C Paton, Clifford M Snapper.   

Abstract

Little is known regarding the role of Toll-like receptors (TLRs) in regulating protein- and polysaccharide-specific immunoglobulin (Ig) isotype production in response to an in vivo challenge with an extracellular bacterium. In this report we demonstrate that MyD88(-/-), but not TLR2(-/-), mice are markedly defective in their induction of multiple splenic proinflammatory cytokine- and chemokine-specific mRNAs after intraperitoneal (i.p.) challenge with heat-killed Streptococcus pneumoniae capsular type 14 (S. pneumoniae type 14). This is correlated with analogous responses in splenic cytokine protein release in vitro following addition of S. pneumoniae type 14. Consistent with these data, naive MyD88(-/-), but not TLR2(-/-), mice are more sensitive to killing following i.p. challenge with live S. pneumoniae type 14, relative to responses in wild-type mice. However, prior immunization of MyD88(-/-) mice with heat-killed S. pneumoniae type 14 protects against an otherwise-lethal challenge with live S. pneumoniae type 14. Surprisingly, both MyD88(-/-) and TLR2(-/-) mice exhibit striking and equivalent defects in elicitation of type 1 IgG isotypes (IgG3, IgG2b, and IgG2a), but not the type 2 IgG isotype, IgG1, specific for several protein and polysaccharide antigens, in response to i.p. challenge with heat-killed S. pneumoniae type 14. Of note, the type 1 IgG isotype titers specific for pneumococcal surface protein A are reduced in MyD88(-/-) mice but not TLR2(-/-) mice. These data suggest that distinct TLRs may differentially regulate innate versus adaptive humoral immunity to intact S. pneumoniae and are the first to implicate a role for TLR2 in shaping an in vivo type 1 IgG humoral immune response to a gram-positive extracellular bacterium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15618166      PMCID: PMC538967          DOI: 10.1128/IAI.73.1.298-307.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

2.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Authors:  O Takeuchi; K Hoshino; T Kawai; H Sanjo; H Takada; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

Review 3.  Toll-like receptors: critical proteins linking innate and acquired immunity.

Authors:  S Akira; K Takeda; T Kaisho
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

4.  CD8- dendritic cell activation status plays an integral role in influencing Th2 response development.

Authors:  A S MacDonald; A D Straw; B Bauman; E J Pearce
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

5.  Toll-like receptors control activation of adaptive immune responses.

Authors:  M Schnare; G M Barton; A C Holt; K Takeda; S Akira; R Medzhitov
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

6.  The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors.

Authors:  A Ozinsky; D M Underhill; J D Fontenot; A M Hajjar; K D Smith; C B Wilson; L Schroeder; A Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

7.  Discrimination of bacterial lipoproteins by Toll-like receptor 6.

Authors:  O Takeuchi; T Kawai; P F Mühlradt; M Morr; J D Radolf; A Zychlinsky; K Takeda; S Akira
Journal:  Int Immunol       Date:  2001-07       Impact factor: 4.823

8.  Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA.

Authors:  A D Ogunniyi; M C Woodrow; J T Poolman; J C Paton
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

9.  Micrococci and peptidoglycan activate TLR2-->MyD88-->IRAK-->TRAF-->NIK-->IKK-->NF-kappaB signal transduction pathway that induces transcription of interleukin-8.

Authors:  Q Wang; R Dziarski; C J Kirschning; M Muzio; D Gupta
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 10.  Chemokines as regulators of T cell differentiation.

Authors:  S A Luther; J G Cyster
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

View more
  42 in total

Review 1.  Pneumococci: immunology of the innate host response.

Authors:  Gavin K Paterson; Carlos J Orihuela
Journal:  Respirology       Date:  2010-07-20       Impact factor: 6.424

2.  Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection.

Authors:  Natalia Muñoz; Laurye Van Maele; Juan M Marqués; Analía Rial; Jean-Claude Sirard; José A Chabalgoity
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

3.  Immunization with a ZmpB-based protein vaccine could protect against pneumococcal diseases in mice.

Authors:  Yi Gong; Wenchun Xu; Yali Cui; Xuemei Zhang; Run Yao; Dairong Li; Hong Wang; Yujuan He; Ju Cao; Yibing Yin
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

4.  Graft-versus-host disease is independent of innate signaling pathways triggered by pathogens in host hematopoietic cells.

Authors:  Hongmei Li; Catherine Matte-Martone; Hung Sheng Tan; Srividhya Venkatesan; Jennifer McNiff; Anthony J Demetris; Dhanpat Jain; Fadi Lakkis; David Rothstein; Warren D Shlomchik
Journal:  J Immunol       Date:  2010-11-22       Impact factor: 5.422

5.  TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae.

Authors:  Katherine S Lee; Charles A Scanga; Eric M Bachelder; Quanyi Chen; Clifford M Snapper
Journal:  Cell Immunol       Date:  2007-05-22       Impact factor: 4.868

6.  A novel ICOS-independent, but CD28- and SAP-dependent, pathway of T cell-dependent, polysaccharide-specific humoral immunity in response to intact Streptococcus pneumoniae versus pneumococcal conjugate vaccine.

Authors:  Quanyi Chen; Jennifer L Cannons; James C Paton; Hisaya Akiba; Pamela L Schwartzberg; Clifford M Snapper
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 7.  Toll-like receptors--sentries in the B-cell response.

Authors:  Isabelle Bekeredjian-Ding; Gaetan Jego
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

Review 8.  Innate B cell helpers reveal novel types of antibody responses.

Authors:  Carola G Vinuesa; Pheh-Ping Chang
Journal:  Nat Immunol       Date:  2013-01-18       Impact factor: 25.606

9.  Pyogenic bacterial infections in humans with MyD88 deficiency.

Authors:  Horst von Bernuth; Capucine Picard; Zhongbo Jin; Rungnapa Pankla; Hui Xiao; Cheng-Lung Ku; Maya Chrabieh; Imen Ben Mustapha; Pegah Ghandil; Yildiz Camcioglu; Júlia Vasconcelos; Nicolas Sirvent; Margarida Guedes; Artur Bonito Vitor; María José Herrero-Mata; Juan Ignacio Aróstegui; Carlos Rodrigo; Laia Alsina; Estibaliz Ruiz-Ortiz; Manel Juan; Claudia Fortuny; Jordi Yagüe; Jordi Antón; Mariona Pascal; Huey-Hsuan Chang; Lucile Janniere; Yoann Rose; Ben-Zion Garty; Helen Chapel; Andrew Issekutz; László Maródi; Carlos Rodriguez-Gallego; Jacques Banchereau; Laurent Abel; Xiaoxia Li; Damien Chaussabel; Anne Puel; Jean-Laurent Casanova
Journal:  Science       Date:  2008-08-01       Impact factor: 47.728

10.  Lack of galectin-3 drives response to Paracoccidioides brasiliensis toward a Th2-biased immunity.

Authors:  Luciana Pereira Ruas; Emerson Soares Bernardes; Marise Lopes Fermino; Leandro Licursi de Oliveira; Daniel K Hsu; Fu-Tong Liu; Roger Chammas; Maria-Cristina Roque-Barreira
Journal:  PLoS One       Date:  2009-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.